Freedom™ System + SCIg
Primary Immunodeficiencies, CIDP
CommercialMarket Expansion
Key Facts
Indication
Primary Immunodeficiencies, CIDP
Phase
Commercial
Status
Market Expansion
Company
About KORU Medical Systems
KORU Medical Systems is a mission-driven company commercializing subcutaneous infusion systems to enable home-based care for chronic therapies, primarily in immunology. A key recent achievement is the FDA clearance of its FreedomEDGE® pump for the administration of UCB's RYSTIGGO® (rozanolixizumab-noli) in generalized myasthenia gravis, validating its strategy of pursuing drug-specific indications. The company leverages a focused commercial team and a 510(k)-cleared platform to target the large and growing market for subcutaneous immunoglobulin (SCIg) and other biologics, aiming to reduce healthcare burdens and improve patient freedom.
View full company profile